Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilvadipine phase III trial in mild to moderate Alzheimer's disease
2012-002764-27Phase 3Completed
- Sponsor
- St James's Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Nilvadipine with Placebo (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale - Cognitive Subscale. Started Nov 2012; status: completed.
02
Drugs
nilvadipine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2012-002764-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002764-27.